Literature DB >> 15229419

A randomized study of the safety of outpatient care for patients with bleeding peptic ulcer treated by endoscopic injection.

Enric Brullet1, Rafel Campo, Xavier Calvet, Merce Guell, Neus Garcia-Monforte, Joan Cabrol.   

Abstract

BACKGROUND: Outpatient management is safe for patients with non-variceal upper-GI bleeding who are at low risk of recurrent bleeding and death. However, outpatient care cannot be offered to many patients because of the presence of risk factors (severe comorbid disorders, major endoscopic stigmata of bleeding, significant hemorrhage). The present study assessed the safety of outpatient management for selected high-risk patients with bleeding peptic ulcer.
METHODS: Patients hospitalized with upper-GI bleeding because of peptic ulcer with a non-bleeding vessel were eligible for inclusion in the study. Inclusion criteria were the following: ulcer size less than 15 mm, absence of hypovolemia, no associated severe disease, and appropriate family support. After endoscopic therapy (injection of epinephrine and polidocanol), patients were randomized to outpatient or hospital care. Patients remained in the emergency ward for a minimum of 6 hours before discharge, during which time omeprazole was administered intravenously. Outpatients were contacted by telephone daily during the first 3 days; a 24-hour telephone hotline was provided for any queries. For both groups, outpatient visits were scheduled at 7 to 10 and 30 days after discharge.
RESULTS: A total of 82 patients were included: 40 were randomized to outpatient care and 42 to hospital care. Clinical and endoscopic variables were similar in both groups. The rate of recurrent bleeding was similar in both groups (4.8% outpatient, 5% hospital). There was no morbidity or mortality in either group at 30 days. Seven patients (17%) randomized to outpatient care received blood transfusion compared with 14 (38%) in the hospital care group (p=0.06). Mean cost of care per patient was significantly lower for the outpatient vs. the hospital group (970 US dollars vs. 1595 US dollars; p < 0.001).
CONCLUSIONS: Selected patients with bleeding peptic ulcer can be safely managed as outpatients after endoscopic therapy. This policy conserves health care resources without compromising standards of care.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15229419     DOI: 10.1016/s0016-5107(04)01314-8

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  6 in total

Review 1.  Update on risk scoring systems for patients with upper gastrointestinal haemorrhage.

Authors:  Adrian J Stanley
Journal:  World J Gastroenterol       Date:  2012-06-14       Impact factor: 5.742

Review 2.  [Endoscopic diagnosis and therapy for gastrointestinal bleeding].

Authors:  M-A Ortner; G Dorta
Journal:  Chirurg       Date:  2006-02       Impact factor: 0.955

Review 3.  Endoscopy for upper gastrointestinal bleeding: how urgent is it?

Authors:  Kelvin K F Tsoi; Terry K W Ma; Joseph J Y Sung
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-07-14       Impact factor: 46.802

Review 4.  Diagnosis and therapy of non-variceal upper gastrointestinal bleeding.

Authors:  Erwin Biecker
Journal:  World J Gastrointest Pharmacol Ther       Date:  2015-11-06

5.  Characteristics and outcomes of gastroduodenal ulcer bleeding: a single-centre experience in Lithuania.

Authors:  Pavel Petrik; Saulė Brašiškienė; Eglė Petrik
Journal:  Prz Gastroenterol       Date:  2017-12-14

6.  Factors Associated with Rebleeding in Patients with Peptic Ulcer Bleeding: Analysis of the Korean Peptic Ulcer Bleeding (K-PUB) Study.

Authors:  Joon Sung Kim; Byung-Wook Kim; Sung Min Park; Ki-Nam Shim; Seong Woo Jeon; Sang-Wook Kim; Yong Chan Lee; Hee Seok Moon; Si Hyung Lee; Woon Tae Jung; Jin Il Kim; Kyoung Oh Kim; Jong-Jae Park; Woo Chul Chung; Jeong Hwan Kim; Gwang Ho Baik; Jung Hwan Oh; Sun Moon Kim; Hyun Soo Kim; Chang Heon Yang; Jin Tae Jung; Chul Hyun Lim; Hyun Joo Song; Yong Sik Kim; Gwang Ha Kim; Jie-Hyun Kim; Jae-Il Chung; Jun Haeng Lee; Min Ho Choi; Jong-Kyoung Choi
Journal:  Gut Liver       Date:  2018-05-15       Impact factor: 4.519

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.